We provide you with 20 years of free, institutional-grade data for TELO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TELO. Explore the full financial landscape of TELO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Telomir Pharmaceuticals(NASDAQ:TELO) 
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.
Founded: 2021
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report about TELO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.